SHENZHEN, CHINA and ROCKVILLE, MD, July 02, 2019 — HighTide Therapeutics Inc. (“HighTide”), a clinical-stage biopharmaceutical company, today announced that Adrian M. Di Bisceglie, M.D., has been appointed as Chief Medical Officer.
July 02, 2019
HighTide Therapeutics is proud to sponsor the annual PSC patient advocacy conference organized by PSC Partners Seeking a Cure. This year the annual conference will take place June 21-23 in Rochester, Minnesota in partnership with Mayo Clini
June 04, 2019
Liping Liu, founder, CEO & CSO of HighTide Therapeutics invited to present at the HKEX Biotech Week 2019 conference, 28-30 May in Hong Kong. Dr. Liu presented HighTide Therapeutics in the “Deep Dive Workshop” on Day 3.
June 02, 2019